Cargando…

Validation of a single biopsy approach and bolus protein feeding to determine myofibrillar protein synthesis in stable isotope tracer studies in humans

BACKGROUND: Minimizing the number of muscle biopsies has important methodological implications and minimizes subject discomfort during a stable isotope amino acid infusion. We aimed to determine the reliability of obtaining a single muscle biopsy for the calculation of muscle protein fractional synt...

Descripción completa

Detalles Bibliográficos
Autores principales: Burd, Nicholas A, West, Daniel WD, Rerecich, Tracy, Prior, Todd, Baker, Steven K, Phillips, Stuart M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068071/
https://www.ncbi.nlm.nih.gov/pubmed/21388545
http://dx.doi.org/10.1186/1743-7075-8-15
_version_ 1782201176353144832
author Burd, Nicholas A
West, Daniel WD
Rerecich, Tracy
Prior, Todd
Baker, Steven K
Phillips, Stuart M
author_facet Burd, Nicholas A
West, Daniel WD
Rerecich, Tracy
Prior, Todd
Baker, Steven K
Phillips, Stuart M
author_sort Burd, Nicholas A
collection PubMed
description BACKGROUND: Minimizing the number of muscle biopsies has important methodological implications and minimizes subject discomfort during a stable isotope amino acid infusion. We aimed to determine the reliability of obtaining a single muscle biopsy for the calculation of muscle protein fractional synthetic rate (FSR) as well as the amount of incorporation time necessary to obtain that biopsy after initiating a stable isotope infusion (Study 1). The calculation of muscle protein FSR requires tracer steady-state during the stable isotope infusion. Therefore, a second aim was to examine if steady-state conditions are compromised in the precursor pools (plasma free or muscle intracellular [IC]) after ingestion of a tracer enriched protein drink and after resistance exercise (Study 2). METHODS: Sixteen men (23 ± 3 years; BMI = 23.8 ± 2.2 kg/m(2), means ± SD) were randomized to perform Study 1 or Study 2 (n = 8, per study). Subjects received a primed, constant infusion of L-[ring-(13)C(6)]phenylalanine coupled with muscle biopsies of the vastus lateralis to measure rates of myofibrillar protein synthesis (MPS). Subjects in Study 2 were fed 25 g of whey protein immediately after an acute bout of unilateral resistance exercise. RESULTS: There was no difference (P = 0.3) in rates of MPS determined using the steady-state precursor-product equation and determination of tracer incorporation between sequential biopsies 150 min apart or using plasma protein as the baseline enrichment, provided the infusion length was sufficient (230 ± 0.3 min). We also found that adding a modest amount of tracer (4% enriched), calculated based on the measured phenylalanine content of the protein (3.5%) in the drink, did not compromise steady-state conditions (slope of the enrichment curve not different from zero) in the plasma free or, more importantly, the IC pool (both P > 0.05). CONCLUSIONS: These data demonstrate that the single biopsy approach yields comparable rates of muscle protein synthesis, provided a longer incorporation time is utilized, to that seen with a traditional two biopsy approach. In addition, we demonstrate that enriching protein-containing drinks with tracer does not disturb isotopic steady-state and thus both are reliable techniques to determine rates of MPS in humans.
format Text
id pubmed-3068071
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30680712011-03-31 Validation of a single biopsy approach and bolus protein feeding to determine myofibrillar protein synthesis in stable isotope tracer studies in humans Burd, Nicholas A West, Daniel WD Rerecich, Tracy Prior, Todd Baker, Steven K Phillips, Stuart M Nutr Metab (Lond) Methodology BACKGROUND: Minimizing the number of muscle biopsies has important methodological implications and minimizes subject discomfort during a stable isotope amino acid infusion. We aimed to determine the reliability of obtaining a single muscle biopsy for the calculation of muscle protein fractional synthetic rate (FSR) as well as the amount of incorporation time necessary to obtain that biopsy after initiating a stable isotope infusion (Study 1). The calculation of muscle protein FSR requires tracer steady-state during the stable isotope infusion. Therefore, a second aim was to examine if steady-state conditions are compromised in the precursor pools (plasma free or muscle intracellular [IC]) after ingestion of a tracer enriched protein drink and after resistance exercise (Study 2). METHODS: Sixteen men (23 ± 3 years; BMI = 23.8 ± 2.2 kg/m(2), means ± SD) were randomized to perform Study 1 or Study 2 (n = 8, per study). Subjects received a primed, constant infusion of L-[ring-(13)C(6)]phenylalanine coupled with muscle biopsies of the vastus lateralis to measure rates of myofibrillar protein synthesis (MPS). Subjects in Study 2 were fed 25 g of whey protein immediately after an acute bout of unilateral resistance exercise. RESULTS: There was no difference (P = 0.3) in rates of MPS determined using the steady-state precursor-product equation and determination of tracer incorporation between sequential biopsies 150 min apart or using plasma protein as the baseline enrichment, provided the infusion length was sufficient (230 ± 0.3 min). We also found that adding a modest amount of tracer (4% enriched), calculated based on the measured phenylalanine content of the protein (3.5%) in the drink, did not compromise steady-state conditions (slope of the enrichment curve not different from zero) in the plasma free or, more importantly, the IC pool (both P > 0.05). CONCLUSIONS: These data demonstrate that the single biopsy approach yields comparable rates of muscle protein synthesis, provided a longer incorporation time is utilized, to that seen with a traditional two biopsy approach. In addition, we demonstrate that enriching protein-containing drinks with tracer does not disturb isotopic steady-state and thus both are reliable techniques to determine rates of MPS in humans. BioMed Central 2011-03-09 /pmc/articles/PMC3068071/ /pubmed/21388545 http://dx.doi.org/10.1186/1743-7075-8-15 Text en Copyright ©2011 Burd et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Burd, Nicholas A
West, Daniel WD
Rerecich, Tracy
Prior, Todd
Baker, Steven K
Phillips, Stuart M
Validation of a single biopsy approach and bolus protein feeding to determine myofibrillar protein synthesis in stable isotope tracer studies in humans
title Validation of a single biopsy approach and bolus protein feeding to determine myofibrillar protein synthesis in stable isotope tracer studies in humans
title_full Validation of a single biopsy approach and bolus protein feeding to determine myofibrillar protein synthesis in stable isotope tracer studies in humans
title_fullStr Validation of a single biopsy approach and bolus protein feeding to determine myofibrillar protein synthesis in stable isotope tracer studies in humans
title_full_unstemmed Validation of a single biopsy approach and bolus protein feeding to determine myofibrillar protein synthesis in stable isotope tracer studies in humans
title_short Validation of a single biopsy approach and bolus protein feeding to determine myofibrillar protein synthesis in stable isotope tracer studies in humans
title_sort validation of a single biopsy approach and bolus protein feeding to determine myofibrillar protein synthesis in stable isotope tracer studies in humans
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068071/
https://www.ncbi.nlm.nih.gov/pubmed/21388545
http://dx.doi.org/10.1186/1743-7075-8-15
work_keys_str_mv AT burdnicholasa validationofasinglebiopsyapproachandbolusproteinfeedingtodeterminemyofibrillarproteinsynthesisinstableisotopetracerstudiesinhumans
AT westdanielwd validationofasinglebiopsyapproachandbolusproteinfeedingtodeterminemyofibrillarproteinsynthesisinstableisotopetracerstudiesinhumans
AT rerecichtracy validationofasinglebiopsyapproachandbolusproteinfeedingtodeterminemyofibrillarproteinsynthesisinstableisotopetracerstudiesinhumans
AT priortodd validationofasinglebiopsyapproachandbolusproteinfeedingtodeterminemyofibrillarproteinsynthesisinstableisotopetracerstudiesinhumans
AT bakerstevenk validationofasinglebiopsyapproachandbolusproteinfeedingtodeterminemyofibrillarproteinsynthesisinstableisotopetracerstudiesinhumans
AT phillipsstuartm validationofasinglebiopsyapproachandbolusproteinfeedingtodeterminemyofibrillarproteinsynthesisinstableisotopetracerstudiesinhumans